ArticleComputer methods and programs in biomedicine2022
WVALE: Weak variational autoencoder for localisation and enhancement of COVID-19 lung infections.
Article in Computer methods and programs in biomedicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Using Variational Autoencoders for Out of Distribution Detection in Histological Multiple Instance Learning.IEEE access : practical innovations, open solutions · 2025Article
- An Artificial Intelligence-Based Automatic Classifier for the Presence of False Lumen Thrombosis After Frozen Elephant Trunk Operation.Diagnostics (Basel, Switzerland) · 2024Article
- Automatic Classification of Magnetic Resonance Histology of Peripheral Arterial Chronic Total Occlusions Using a Variational Autoencoder: A Feasibility Study.Diagnostics (Basel, Switzerland) · 2023Article
- Hybrid feature engineering of medical data via variational autoencoders with triplet loss: a COVID-19 prognosis study.Scientific reports · 2023Article
- Weakly supervised segmentation of COVID-19 infection with local lesion coherence on CT images.Biomedical signal processing and control · 2023Article
- EVAE-Net: An Ensemble Variational Autoencoder Deep Learning Network for COVID-19 Classification Based on Chest X-ray Images.Diagnostics (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveThe COVID-19 pandemic is a major global health crisis of this century. The use of neural networks with CT imaging can potentially improve clinicians' efficiency in diagnosis. Previous studies in this field have primarily focused on classifying the disease on CT images, while few studies targeted the localisation of disease regions. Developing neural networks for automating the latter task is impeded by limited CT images with pixel-level annotations available to the research community.
methodsThis paper proposes a weakly-supervised framework named "Weak Variational Autoencoder for Localisation and Enhancement" (WVALE) to address this challenge for COVID-19 CT images. This framework includes two components: anomaly localisation with a novel WVAE model and enhancement of supervised segmentation models with WVALE.
resultsThe WVAE model have been shown to produce high-quality post-hoc attention maps with fine borders around infection regions, while weak supervision segmentation shows results comparable to conventional supervised segmentation models. The WVALE framework can enhance the performance of a range of supervised segmentation models, including state-of-art models for the segmentation of COVID-19 lung infection.
conclusionsOur study provides a proof-of-concept for weakly supervised segmentation and an alternative approach to alleviate the lack of annotation, while its independence from classification & segmentation frameworks makes it easily integrable with existing systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.